Archive for November 2nd, 2008

News: Positive Clinical Data with Santarus' ZEGERID Capsules in …

Sunday, November 2nd, 2008

Santarus, Inc. (NASDAQ:SNTS), a specialty pharmaceutical company,
today announced the presentation of an abstract at the Digestive
Disease Week (DDW) annual meeting of positive pharmacodynamic study
results indicating that, after seven days of pre-breakfast dosing,
ZEGERID(R) (omeprazole/sodium bicarbonate) Capsules 40 mg/1100 mg
produced significantly greater and sig…